Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers

计划入组 6 人 · 首次发布于 2011 年 2 月 18 日

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen

计划入组 93 人 · 首次发布于 2014 年 3 月 18 日

The Effect of L-lysine on Human Gastrointestinal Secretion: A Dose-finding Study Applying Magnetic Resonance Imaging (MRI)

计划入组 6 人 · 首次发布于 2012 年 4 月 18 日

BioBarrier

PLGA Poly-L-Lysine

alpha-poly-L-lysine + poly-L-glutamate

POLY MEDICURE LIMITED

India

Poly Pharmaceuticals Inc

United States

CLEVELAND CLINIC ABUDHABI L L C

United Arab Emirates

NIH Grants Exclusive License to Sangam Lifesciences for Novel Cancer Drug Delivery Platform

PLL Therapeutics to Initiate Phase I/II Trial of PLL001 for Amyotrophic Lateral Sclerosis in Australia

Magnetic Nanoparticles Enhance Amphotericin B Delivery Against Leishmaniasis with Reduced Toxicity